Dynatronics (NASDAQ:DYNT) Lifted to Hold at Zacks Investment Research


Share on StockTwits

Zacks Investment Research upgraded shares of Dynatronics (NASDAQ:DYNT) from a sell rating to a hold rating in a report released on Wednesday, Zacks.com reports.

According to Zacks, “DYNATRONICS CORP. is involved in the design, manufacture and sale of medical devices for therapeutic use by medical practitioners. “

Separately, Aegis reissued a buy rating on shares of Dynatronics in a research note on Monday, February 15th.

DYNT opened at $1.13 on Wednesday. The stock has a fifty day simple moving average of $1.23 and a two-hundred day simple moving average of $0.97. The company has a current ratio of 2.00, a quick ratio of 1.22 and a debt-to-equity ratio of 0.52. The company has a market cap of $16.92 million, a price-to-earnings ratio of -2.83 and a beta of -0.04. Dynatronics has a 12-month low of $0.52 and a 12-month high of $2.56.

Dynatronics (NASDAQ:DYNT) last released its earnings results on Wednesday, February 10th. The medical equipment provider reported ($0.06) EPS for the quarter, missing analysts’ consensus estimates of ($0.05) by ($0.01). Dynatronics had a negative return on equity of 35.41% and a negative net margin of 7.94%. The company had revenue of $11.97 million during the quarter, compared to analysts’ expectations of $11.34 million. On average, analysts predict that Dynatronics will post -0.15 EPS for the current year.

A hedge fund recently raised its stake in Dynatronics stock. Virtu Financial LLC raised its position in shares of Dynatronics Co. (NASDAQ:DYNT) by 123.2% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 77,860 shares of the medical equipment provider’s stock after acquiring an additional 42,984 shares during the period. Virtu Financial LLC owned approximately 0.52% of Dynatronics worth $63,000 as of its most recent filing with the Securities and Exchange Commission (SEC). 7.52% of the stock is owned by hedge funds and other institutional investors.

About Dynatronics

Dynatronics Corporation, a medical device company, designs, manufactures, and sells physical therapy, rehabilitation, orthopedics, pain management, and athletic training products in the United States. It offers orthopedic soft bracing products, which include cervical collars, shoulder immobilizers, arm slings, wrist and elbow supports, abdominal and lumbosacral supports, maternity supports, knee immobilizers and supports, ankle walkers and supports, plantar fasciitis splints, and cold therapy products.

Further Reading: Market Capitalization – What it Means for Investors

Get a free copy of the Zacks research report on Dynatronics (DYNT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Dynatronics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dynatronics and related companies with MarketBeat.com's FREE daily email newsletter.